Literature DB >> 3872558

MR imaging of systemic lupus erythematosus involving the brain.

A M Aisen, T O Gabrielsen, W J McCune.   

Abstract

Focal lesions were demonstrated on magnetic resonance (MR) imaging in eight patients with systemic lupus erythematosus and recent onset of neuropsychiatric symptoms. Corresponding findings were visible in only two of seven patients who had computed tomographic (CT) scans. Three patterns of disease were observed on MR when it was performed with a pulse repetition rate of 2000 msec. The first pattern was that of cerebral infarction, with a relatively large area of increased intensity. The second pattern, multiple small areas of increased intensity, may have been secondary to microinfarctions. The third pattern was that of focal areas of increased intensity, predominantly in the cerebral gray matter. In two of three patients with the third pattern, partial or complete resolution was observed on follow-up MR images obtained several weeks after the initial studies.

Entities:  

Mesh:

Year:  1985        PMID: 3872558     DOI: 10.2214/ajr.144.5.1027

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  14 in total

1.  Systemic inflammatory disorders in patients admitted for aseptic meningitis.

Authors:  Marine Boudot de la Motte; Rachid Abbas; Fanny Jouan; Damien van Gysel; Marie Paule Chauveheid; Thomas Papo; Karim Sacre
Journal:  Clin Med (Lond)       Date:  2018-03       Impact factor: 2.659

2.  Correlation of neurocognitive function and brain lesion load on magnetic resonance imaging in systemic lupus erythematosus.

Authors:  Paola C Roldan; Rex E Jung; Wilmer L Sibbitt; Clifford R Qualls; Ranee A Flores; Carlos A Roldan
Journal:  Rheumatol Int       Date:  2018-06-13       Impact factor: 2.631

3.  Magnetic resonance imaging in infections of the brain: findings in tuberculosis, listeriosis, toxoplasmosis, subacute sclerosing panencephalitis, and multiple sclerosis.

Authors:  M Just; H P Higer; G Krämer; G Golla; O Betting; H Holper; P Pfannenstiel
Journal:  Neurosurg Rev       Date:  1987       Impact factor: 3.042

4.  MR brain scanning in patients with vasculitis: differentiation from multiple sclerosis.

Authors:  D H Miller; I E Ormerod; A Gibson; E P du Boulay; P Rudge; W I McDonald
Journal:  Neuroradiology       Date:  1987       Impact factor: 2.804

5.  Systemic lupus erythematosus presenting with neurological disorders.

Authors:  M R Tola; E Granieri; L Caniatti; E Paolino; C Monetti; L Dovigo; R Scolozzi; P De Bastiani; M Carreras
Journal:  J Neurol       Date:  1992-02       Impact factor: 4.849

6.  MRI changes in the central nervous system in a child with lupus erythematosus.

Authors:  M A Gieron; S Khoromi; A Campos
Journal:  Pediatr Radiol       Date:  1995

7.  Brain single-photon emission tomography with 99mTc-HMPAO in neuropsychiatric systemic lupus erythematosus: relations with EEG and MRI findings and clinical manifestations.

Authors:  P Colamussi; M Giganti; C Cittanti; L Dovigo; F Trotta; M R Tola; R Tamarozzi; G Lucignani; A Piffanelli
Journal:  Eur J Nucl Med       Date:  1995-01

8.  Single photon emission computed tomography in systemic lupus erythematosus with psychiatric symptoms.

Authors:  K Kodama; S Okada; T Hino; K Takabayashi; Y Nawata; Y Uchida; N Yamanouchi; N Komatsu; T Ikeda; N Shinoda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-03       Impact factor: 10.154

9.  Brain magnetic resonance imaging in newly diagnosed systemic lupus erythematosus.

Authors:  Michelle Petri; Mohammad Naqibuddin; Kathryn A Carson; Daniel J Wallace; Michael H Weisman; Stephen L Holliday; Margaret Sampedro; Shalini Narayana; Peter T Fox; Crystal Franklin; Patricia A Padilla; Robin L Brey
Journal:  J Rheumatol       Date:  2008-09-15       Impact factor: 4.666

10.  18FDG PET and acetazolamide-enhanced 99mTc-HMPAO SPET in systemic lupus erythematosus.

Authors:  F Grünwald; A Schomburg; A Badali; J Ruhlmann; L Pavics; H J Biersack
Journal:  Eur J Nucl Med       Date:  1995-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.